Help Find A Cure For ALS!

WELCOME TO THE ANGEL FUND FOR ALS RESEARCH

The Angel Fund for ALS Research (Angel Fund, Inc.) is an independent non-profit charity (04-3478977) dedicated to supporting ALS (Lou Gehrig’s Disease) investigations at the Cecil B. Day Laboratory for Neuromuscular Research at UMass Chan Medical School in Worcester, MA, internationally recognized for its ground-breaking work in the fight against this devastating illness.

The Angel Fund is special.

We are not a national charity – we are local. We have very low overhead and administrative costs.

Why are they so passionate?

Because most have lived through the heartbreak of seeing their loved one live with ALS and lose their battle to this horrific disease.


100 Innings of Baseball

The 100 Innings of Baseball was highlighted in the Boston Globe today! Thank you to Stan Grossfeld for his wonderful story about our superheroes who participated - players and umpires and their leader Walter Bentson.

Our mission is to support ALS (Lou Gehrig’s Disease) research and scientific investigations at the Cecil B. Day Laboratory by raising funds through events, campaigns, foundation grants and numerous other community outreach activities, to aid in finding a cause, treatment and cure for ALS.

Our Non-Profit Setup

Our offices are located in the law firm of Nigro Pettipet and Lucas, courtesy of Directors Jan and Eugene Nigro. Angel Fund President Rich Kennedy and the board members are not paid. As a result, it means we have very low overhead and administrative costs so more money goes to research. We are proud to say that 92% of funds expended goes to research.

  • No rent
  • No utility bills
  • No high paid executives

Pilot human study shows novel treatment suppresses mutant ALS gene

(Wakefield, MA) – A clinical trial funded by The Angel Fund for ALS Research has shown significant progress in suppressing expression of the most commonly mutated ALS gene, C9ORF72 (C9). The C9 gene mutation, a lengthy expansion of a repeated segment of six molecules of DNA, causes both familial ALS and frontotemporal dementia. The results of the human trial, initiated and led by Drs. Robert H. Brown and Jonathan Watts at UMass Chan Medical School, were published in Nature Medicine.

 

Fundraising Events

All Fundraising Events

Latest News Entries

January 9, 2022
News

ALS Research Update

Brief Summary and Research Update August 1, 2022 ALS Program – UMass Chan Medical School By Dr. Robert H. Brown, Jr. Over the last several months, ALS investigations at UMass Chan Medical School have had excellent momentum.  Collaborating with Prof. Paul Greer in the Program in Molecular Medicine at UMass, Dr. Brown has further characterized […]

News

ALS Research Update
December 28, 2021
News

Groundbreaking News for ALS Research

Pilot human study shows novel treatment suppresses mutant ALS gene The Angel Fund for ALS Research provides major funding (Wakefield, MA) – A clinical trial funded by The Angel Fund for ALS Research has shown significant progress in suppressing expression of the most commonly mutated ALS gene, C9ORF72 (C9). The C9 gene mutation, a lengthy […]

News

Groundbreaking News for ALS Research

Our Partners

Kings
Harpoon 5 Miler
Subaru
Sharon Timlin 5 Miler
The Hanover Group
Nigro Pettepit and Lucas Law Offices
UMass Medical School
TSB
Tracelink
Alexion

Angel Fund supporters make a difference in fighting ALS, and you can be one of them.

Become a Volunteer

Copyrights © 2019 All Rights Reserved. Powered by Pixel Junction.

Join Us Now!